Skip to content

The effect of mechanical ventilation during cardiopulmonary bypass surgery in adult cardiac valve surgery on inflammatory responses and pulmonary function

The effect of mechanical ventilation during cardiopulmonary bypass surgery in adult cardiac valve surgery on inflammatory responses and pulmonary function

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20211026052875N1
Enrollment
60
Registered
2021-11-21
Start date
2021-11-22
Completion date
Unknown
Last updated
2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases of the respiratory system. Acute respiratory failure

Interventions

Intervention 1: Intervention group: In this study, mechanical ventilation with TV = 3cc / Kg, RR = 6, PEEP = 5 and FI02 = 1 continues in the intervention group during cardiopulmonary bypass and blood

Sponsors

Rajaie Cardiovascular, Medical and Research Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to No maximum

Inclusion criteria

Inclusion criteria: ? All adult patients with age >35y undergoing elective cardiac valve surgery

Exclusion criteria

Exclusion criteria: patients undergoing emergency surgery Patients undergoing congenital heart surgery Patients undergoing third and more valve resections Patients with coagulation disease Patients undergoing dialysis Patients with pulmonary problems such as COPD who are in stage one and four due to FEV1 ( stage1:mild FEV1=80%? stage2:moderate FEV1 50-79%? stage3:severe FEV130-49% ? stage 4: very severe FEV1 =30% ) Patients with fractional ejection less than 35%, Patients who transfer to the ICU with open sternum In this study, if the surgeon's vision decreases during cardiac surgery due to continued mechanical ventilation, the ventilation will stop and the patient will be excluded from the study Patients who remain intubated for more than 12 hours after transfer to the ICU due to hemodynamic instability patients who are transferred to the operating room for any reason

Design outcomes

Primary

MeasureTime frame
Inflammatory cytokines (IL-6, IL-8, IL-10,INT gamma,TNF alph). Timepoint: After induction of anesthesia and placement of the central vein; after separation from cardiopulmonary bypass; after extubation. Method of measurement: Inflammatory cytokines using venous blood samples in operation room and ICU.;Respiratory test. Timepoint: The day before surgery, the seventh day after surgery. Method of measurement: PFT and 6min Walking test before and after surgery.

Secondary

MeasureTime frame
Length of stay in hospital and intensive care unit. Timepoint: After discharge from hospital. Method of measurement: length of stay in hospital and intensive care unit according to patient records.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh shima Hadipourzadeh

Iran University of Medical Sciences

shimahadipoorzadeh@gmail.com+98 21 2392 3740

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026